Chemoinformaics analysis of gamma-Aminobutyric acid
| Molecular Weight | 103.121 | nRot | 3 |
| Heavy Atom Molecular Weight | 94.049 | nRig | 11 |
| Exact Molecular Weight | 103.063 | nRing | 0 |
| Solubility: LogS | -5.178 | nHRing | 0 |
| Solubility: LogP | 5.469 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 15.3851 |
| nHD | 2 | BPOL | 9.32686 |
| QED | 0.535 |
| Synth | 3.768 |
| Natural Product Likeliness | 3.058 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.942 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.495 |
| MDCK | 0.0000162 |
| BBB | 0.083 |
| PPB | 0.977316 |
| VDSS | 5.046 |
| FU | 0.0222341 |
| CYP1A2-inh | 0.387 |
| CYP1A2-sub | 0.595 |
| CYP2c19-inh | 0.296 |
| CYP2c19-sub | 0.943 |
| CYP2c9-inh | 0.27 |
| CYP2c9-sub | 0.648 |
| CYP2d6-inh | 0.177 |
| CYP2d6-sub | 0.41 |
| CYP3a4-inh | 0.485 |
| CYP3a4-sub | 0.425 |
| CL | 10.404 |
| T12 | 0.081 |
| hERG | 0.011 |
| Ames | 0.009 |
| ROA | 0.055 |
| SkinSen | 0.046 |
| Carcinogencity | 0.879 |
| EI | 0.275 |
| Respiratory | 0.222 |
| NR-Aromatase | 0.029 |
| Antiviral | No |
| Prediction | 0.95997 |